Early neoplastic lymphoid lesions

Seminars in Diagnostic Pathology

Volumn 30, Issue 2, 2013, Pages 146-155

  Carvajal Cuenca, Alejandra ^a   Campo, Elías ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

"In situ" follicular lymphoma; "In situ" mantle cell lymphoma; Atypical lymphoid hyperplasias; Early lymphoid lesions; Monoclonal B cell lymphocytosis

Indexed keywords

IMMUNOGLOBULIN; LEUKOSIALIN; TRANSCRIPTION FACTOR SOX11;

ARTICLE; ATYPICAL LYMPHOID HYPERPLASIA; ATYPICAL MARGINAL ZONE HYPERPLASIA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE GENITAL TRACT FLORID REACTIVE LYMPHOID HYPERPLASIA; FLOW CYTOMETRY; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU FOLLICULAR LYMPHOMA; IN SITU MANTLE CELL LYMPHOMA; LYMPHATIC SYSTEM DISEASE; LYMPHOCYTOMA; LYMPHOID HYPERPLASIA; LYMPHOPROLIFERATIVE DISEASE; MONOCLONAL B CELL LYMPHOCYTOSIS; PRIORITY JOURNAL;

DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; HUMANS; LYMPHOID TISSUE; LYMPHOMA; LYMPHOPROLIFERATIVE DISORDERS; PSEUDOLYMPHOMA;

EID: 84879845617     PISSN: 07402570     EISSN: 19301111     Source Type: Journal    
DOI: 10.1053/j.semdp.2012.08.008     Document Type: Article

References (49)

1. Swerdlow S.H. Genetic and molecular genetic studies in the diagnosis of atypical lymphoid hyperplasias versus lymphoma. Hum Pathol. 2003, 34:346-351.
2. Iijima T., Inadome Y., Noguchi M. Clonal proliferation of B lymphocytes in the germinal centers of human reactive lymph nodes: possibility of overdiagnosis of B cell clonal proliferation. Diagn Mol Pathol. 2000, 9:132-136.
3. Zhou X.G., Sandvej K., Gregersen N., et al. Detection of clonal B cells in microdissected reactive lymphoproliferations: possible diagnostic pitfalls in PCR analysis of immunoglobulin heavy chain gene rearrangement. Mol Pathol. 1999, 52:104-110.
4. Saxena A., Moshynska O., Kanthan R., et al. Distinct B-cell clonal bands in Helicobacter pylori gastritis with lymphoid hyperplasia. J Pathol. 2000, 190:47-54.
5. Hummel M., Oeschger S., Barth T.F., et al. Wotherspoon criteria combined with B cell clonality analysis by advanced polymerase chain reaction technology discriminates covert gastric marginal zone lymphoma from chronic gastritis. Gut. 2006, 55:782-787.
6. Kussick S.J., Kalnoski M., Braziel R.M., et al. Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations. Am J Clin Pathol. 2004, 121:464-472.
7. Nam-Cha S.H., San-Millan B., Mollejo M., et al. Light-chain-restricted germinal centres in reactive lymphadenitis: report of eight cases. Histopathology. 2008, 52:436-444.
8. Attygalle A.D., Liu H., Shirali S., et al. Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. Blood. 2004, 104:3343-3348.
9. Geyer J.T., Ferry J.A., Harris N.L., et al. Florid reactive lymphoid hyperplasia of the lower female genital tract (lymphoma-like lesion): a benign condition that frequently harbors clonal immunoglobulin heavy chain gene rearrangements. Am J Surg Pathol. 2010, 34:161-168.
10. Rizzo K.A., Streubel B., Pittaluga S., et al. Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR. Mod Pathol. 2010, 23:866-873.
11. Lee P.S., Beneck D., Weisberger J., et al. Coexpression of CD43 by benign B cells in the terminal ileum. Appl Immunohistochem Mol Morphol. 2005, 13:138-141.
12. Dyer M.J., Ye H., Isaacson P.G. Primary lymphoma-like lesions of the uterine cervix; sheep in wolves' clothing. Br J Haematol. 2011, 153:791-794.
13. Extranodal Lymphomas 2011, Elsevier Saunders, Philadelphia. 1st ed. J.A. Ferry (Ed.).
14. Marti G.E., Rawstron A.C., Ghia P., et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol. 2005, 130:325-332.
15. Rawstron A.C., Green M.J., Kuzmicki A., et al. Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood. 2002, 100:635-639.
16. Shanafelt T.D., Ghia P., Lanasa M.C., et al. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia. 2010, 24:512-520.
17. Rawstron A.C., Bennett F.L., O'Connor S.J., et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med. 2008, 359:575-583.
18. Nieto W.G., Almeida J., Romero A., et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood. 2009, 114:33-37.
19. Ghia P. Another piece of the puzzle: is there a "nodal" monoclonal B-cell lymphocytosis?. Haematologica. 2011, 96:1089-1091.
20. Landgren O., Albitar M., Ma W., et al. B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med. 2009, 360:659-667.
21. Crowther-Swanepoel D., Di Bernardo M.C., Jamroziak K., et al. Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk. Br J Haematol. 2011, 154:229-233.
22. Dagklis A., Fazi C., Sala C., et al. The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring. Blood. 2009, 114:26-32.
23. Amato D., Oscier D.G., Davis Z., et al. Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5-monoclonal B-cell lymphocytosis. Am J Clin Pathol. 2007, 128:333-338.
24. Hallek M., Cheson B.D., Catovsky D., et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008, 111:5446-5456.
25. Muller-Hermelink H.K., Montserrat E., Catovsky D., Campo E., Harris N.L., Stein H. Chronic lymphocytic leukaemia/small lymphocytic lymphoma. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, 180-184. IARC, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S. Pileri, H. Stein (Eds.).
26. Gibson S.E., Swerdlow S.H., Ferry J.A., et al. Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. Haematologica. 2011, 96:1144-1152.
27. Campo E., Swerdlow S.H., Harris N.L., et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011, 117:5019-5032.
28. Jegalian A.G., Eberle F.C., Pack S.D., et al. Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma. Blood. 2011, 118:2976-2984.
29. Cong P., Raffeld M., Teruya-Feldstein J., et al. In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood. 2002, 99:3376-3382.
30. Montes-Moreno S., Castro Y., Rodriguez-Pinilla S.M., et al. Intrafollicular neoplasia/in situ follicular lymphoma: review of a series of 13 cases. Histopathology. 2010, 56:658-662.
31. Nodit L., Bahler D.W., Jacobs S.A., et al. Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes. Hum Pathol. 2003, 34:1030-1034.
32. Espinet B., Sole F., Pedro C., et al. Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma?. Hum Pathol. 2005, 36:1232-1237.
33. Richard P., Vassallo J., Valmary S., et al. "In situ-like" mantle cell lymphoma: a report of two cases. J Clin Pathol. 2006, 59:995-996.
34. Aqel N., Barker F., Patel K., et al. In-situ mantle cell lymphoma-a report of two cases. Histopathology. 2008, 52:256-260.
35. Bassarova A., Tierens A., Lauritzsen G.F., et al. Mantle cell lymphoma with partial involvement of the mantle zone: an early infiltration pattern of mantle cell lymphoma?. Virchows Arch. 2008, 453:407-411.
36. Roullet M.R., Martinez D., Ma L., et al. Coexisting follicular and mantle cell lymphoma with each having an in situ component: a novel, curious, and complex consultation case of coincidental, composite, colonizing lymphoma. Am J Clin Pathol. 2010, 133:584-591.
37. Lecluse Y., Lebailly P., Roulland S., et al. t(11;14)-Positive clones can persist over a long period of time in the peripheral blood of healthy individuals. Leukemia. 2009, 23:1190-1193.
38. Carvajal-Cuenca A, Sua LF, Silva NM, et al. In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haemetologica. 2012;97:270-278.
39. Adam P., Katzenberger T., Eifert M., et al. Presence of preserved reactive germinal centers in follicular lymphoma is a strong histopathologic indicator of limited disease stage. Am J Surg Pathol. 2005, 29:1661-1664.
40. Roulland S., Navarro J.M., Grenot P., et al. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J Exp Med. 2006, 203:2425-2431.
41. Agopian J., Navarro J.M., Gac A.C., et al. Agricultural pesticide exposure and the molecular connection to lymphomagenesis. J Exp Med. 2009, 206:1473-1483.
42. Liu Y., Hernandez A.M., Shibata D., et al. BCL2 translocation frequency rises with age in humans. Proc Nat Acad Sci USA. 1994, 91:8910-8914.
43. Henopp T., Quintanilla-Martinez L., Fend F., et al. Prevalence of follicular lymphoma in situ in consecutively analysed reactive lymph nodes. Histopathology. 2011, 59:139-142.
44. Racke F, Simpson S, Christian B, et al. Evidence of long latency periods prior to development of mantle cell lymphoma. Presented at 52nd ASH Annual Meeting (abst. 323); 2010.
45. Christian B., Zhao W., Hamadani M., et al. Mantle cell lymphoma 12 years after allogeneic bone marrow transplantation occurring simultaneously in recipient and donor. J Clin Oncol. 2010, 28:e629-e632.
46. Dictor M., Ek S., Sundberg M., et al. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Haematologica. 2009, 94:1563-1568.
47. Mozos A., Royo C., Hartmann E., et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica. 2009, 94:1555-1562.
48. Fernandez V., Salamero O., Espinet B., et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010, 70:1408-1418.
49. Ondrejka S.L., Lai R., Kumar N., et al. Indolent mantle cell leukemia: clinicopathologic variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis. Haematologica. 2011, 96:1121-1127.